1253 related articles for article (PubMed ID: 25465296)
1. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
2. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
Gajate C; Mollinedo F
J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.
Gajate C; Mollinedo F
Apoptosis; 2015 May; 20(5):584-606. PubMed ID: 25702154
[TBL] [Abstract][Full Text] [Related]
4. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
Mollinedo F; Gajate C
J Lipid Res; 2020 May; 61(5):611-635. PubMed ID: 33715811
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
6. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.
Mollinedo F; Gajate C
Biochem Soc Trans; 2022 Jun; 50(3):1105-1118. PubMed ID: 35587168
[TBL] [Abstract][Full Text] [Related]
7. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
8. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
9. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy.
Mollinedo F; Gajate C
Future Oncol; 2010 May; 6(5):811-21. PubMed ID: 20465392
[TBL] [Abstract][Full Text] [Related]
10. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
11. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
12. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
[TBL] [Abstract][Full Text] [Related]
13. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
[TBL] [Abstract][Full Text] [Related]
14. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
15. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
16. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
17. Lipid raft-targeted therapy in multiple myeloma.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; Campanero MA; Blanco-Prieto MJ
Oncogene; 2010 Jul; 29(26):3748-57. PubMed ID: 20418917
[TBL] [Abstract][Full Text] [Related]
18. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
19. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
20. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis.
Li B; Qin Y; Yu X; Xu X; Yu W
Cell Prolif; 2022 Jan; 55(1):e13167. PubMed ID: 34939255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
